Skip to main content

BlueYard Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

70
Companies
$958.9M
Total invested
$13.7M
Avg. check
54
Industries
Biotechnology 8Artificial Intelligence (AI) 4Medical 4Software 4Manufacturing 3Electronics 3+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 70
Dubsof
October 2026

Dubsof unifies fragmented business data to build custom workflow management apps.

Dublin$6.5M Seed
Sensible Biotechnologies
October 2026

Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.

Artificial Intelligence (AI) · Oxford$27.0M Series A
Chemify
September 2026

Chemify integrates chemistry with robotics and machine learning to digitize the process of molecule creation.

Advanced Materials · Glasgow$29.6M Grant
boxd
September 2026

Persistent, forkable and suspendable virtual machines for agents and agentic workloads.

Cloud Infrastructure · Amsterdam$2.0M Pre-Seed
Transcripta Bio
July 2026

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

Biotechnology · Palo Alto$24.0M Series A
Cryptio
March 2026

Cryptio is a fintech and SaaS company that offer accounting, audit and tax software for digital assets.

Accounting · Paris$45.0M Series B
Aerska
February 2026

Aerska is a biotechnology company that is creating RNA medications to treat, delay, and prevent brain disorders.

Biotechnology · Dublin$39.0M Series A
SeeQC
January 2026

SeeQC is a semiconductor company that develops quantum computing systems and offers chip fabrication services to businesses.

Electronics · Elmsford$19.2M Venture - Series Unknown
bit.bio
January 2026

Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development.

Biotechnology · Cambridge$50.0M Series C
ZeroPhase
December 2025

ZeroPhase creates robust, scalable, software-defined connectivity systems that are independent.

Communications Infrastructure · Unterschleißheim$6.8M Seed
ETHGas
December 2025

ETHGas is a marketplace for Ethereum blockspace commitments.

Information Technology · Hong Kong$12.0M Seed
AnySignal
December 2025

AnySignal is an integrated sensing and communications products company.

Communication Hardware · Gardena$24.0M Series A
Corintis
December 2025

Corintis develops, produces, and tests microfluidic cooling for data center chips.

Electronics · Lausanne$25.0M Corporate Round
Kindred
September 2025

The default interface for all human–AI interaction

Artificial Intelligence (AI) · Singapore$8.3M Seed
Manex
June 2025

Manex is revolutionizing process steering and industrial quality management through its manufacturing optimization agents.

Artificial Intelligence (AI) · Munich$9.1M Seed
Change Bio
May 2025

Change Bio provides an end-to-end manufacturing solution for AI-designed and discovered recombinant proteins

Advanced Materials · London$27K Grant
Grouphug
April 2025

Generates memes from the archive of group WhatsApp chats

Digital Media · Montréal$1.7M Pre-Seed
Dance
March 2025

Dance is an e-bike subscription service where users pay a monthly fee that covers their bikes and provides an all-inclusive support package.

Consumer · Berlin$13.1M Venture - Series Unknown
Miren
February 2025

Miren is a SaaS company that offers an application deployment software.

Application Performance Management · Los Angeles$3.0M Seed
Zafrens
February 2025

Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.

Biotechnology · San DiegoSeries A
Meatable
November 2024

Meatable is a food production company that produces guilt-free meat.

Food and Beverage · LeidenVenture - Series Unknown
Clock Bio
October 2024

Clock Bio operates as a biotech company.

Biotechnology · Cambridge$5.3M Seed
CPTx
September 2024

CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.

Biotechnology · Planegg$29.0M Venture - Series Unknown
Rapidata
February 2026

Rapidata is a data processing platform that offers human-verified innovative datalabeling and data processing services at scale.

Cloud Data Services · Zürich$8.5M Seed

Where BlueYard Capital invests

Biotechnology8
Artificial Intelligence (AI)4
Medical4
Software4
Manufacturing3
Electronics3

About BlueYard Capital's portfolio

How many companies has BlueYard Capital invested in?▸

BlueYard Capital has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BlueYard Capital invest in?▸

BlueYard Capital's top investment sectors include Biotechnology, Artificial Intelligence (AI), Medical, Software, Manufacturing. The firm invests across 54 different industry categories.

What is BlueYard Capital's largest investment?▸

Among tracked funding rounds, bit.bio received $50.0M in a Series C round. BlueYard Capital's total known invested capital is $958.9M.

What is the average investment size for BlueYard Capital?▸

BlueYard Capital's average investment size is $13.7M across its portfolio of 70 companies.

What are BlueYard Capital's most recent investments?▸

Recent BlueYard Capital portfolio additions include Dubsof, Sensible Biotechnologies, Chemify, boxd, Transcripta Bio. These companies were founded in 2020 or later.

Reach the founders behind these 70 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →